Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Gilbert

Showing results (131-140 of 162) with videos related to

Pageof 17
Sort By:
World Journal of Urology|September 22, 2018
Update of the ICUD-SIU International Consultation on Bladder Cancer 2018: urinary diversionOscar Rodríguez Faba, Mark D Tyson, Walter Artibani, et al.
European Urology|March 8, 2020
Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-GuérinRoger Li, Debasish Sundi, Jingsong Zhang, et al.
JAMA Network Open|May 25, 2021
Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell CarcinomaNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.
Urologic Oncology|July 10, 2022
Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancerAhmet Murat Aydin, Salim K Cheriyan, Richard Reich, et al.
The Journal of Urology|May 25, 2021
Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder CancerNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.
CA: a Cancer Journal for Clinicians|April 21, 2020
Innovations in research and clinical care using patient-generated health dataHeather S L Jim, Aasha I Hoogland, Naomi C Brownstein, et al.
European Urology Oncology|February 16, 2023
Cost Effectiveness of Treatment Sequences in Advanced Renal Cell CarcinomaNeil T Mason, Vidhu B Joshi, Jacob J Adashek, et al.
Current Oncology Reports|June 5, 2024
From Detection to Cure - Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder CancerJoshua A Linscott, Hiroko Miyagi, Prithvi B Murthy, et al.
Oncology|November 17, 2011
Combination therapy for renal cell cancer: what are possible options?Napoleon Santos, Justin B Wenger, Pamela Havre, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|October 6, 2022
Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A National Retrospective Cohort StudyBenjamin D Powers, James McDonald, Rahul Mhaskar, et al.
Pageof 17

Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
World Journal of Urology|September 22, 2018
Update of the ICUD-SIU International Consultation on Bladder Cancer 2018: urinary diversionOscar Rodríguez Faba, Mark D Tyson, Walter Artibani, et al.
European Urology|March 8, 2020
Systematic Review of the Therapeutic Efficacy of Bladder-preserving Treatments for Non-muscle-invasive Bladder Cancer Following Intravesical Bacillus Calmette-GuérinRoger Li, Debasish Sundi, Jingsong Zhang, et al.
JAMA Network Open|May 25, 2021
Real-World Survival Outcomes Associated With First-Line Immunotherapy, Targeted Therapy, and Combination Therapy for Metastatic Clear Cell Renal Cell CarcinomaNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.
Urologic Oncology|July 10, 2022
Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancerAhmet Murat Aydin, Salim K Cheriyan, Richard Reich, et al.
The Journal of Urology|May 25, 2021
Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder CancerNicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.
CA: a Cancer Journal for Clinicians|April 21, 2020
Innovations in research and clinical care using patient-generated health dataHeather S L Jim, Aasha I Hoogland, Naomi C Brownstein, et al.
European Urology Oncology|February 16, 2023
Cost Effectiveness of Treatment Sequences in Advanced Renal Cell CarcinomaNeil T Mason, Vidhu B Joshi, Jacob J Adashek, et al.
Current Oncology Reports|June 5, 2024
From Detection to Cure - Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder CancerJoshua A Linscott, Hiroko Miyagi, Prithvi B Murthy, et al.
Oncology|November 17, 2011
Combination therapy for renal cell cancer: what are possible options?Napoleon Santos, Justin B Wenger, Pamela Havre, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|October 6, 2022
Hospital Surgical Volume Is Poorly Correlated With Delivery of Multimodal Treatment for Localized Pancreatic Cancer: A National Retrospective Cohort StudyBenjamin D Powers, James McDonald, Rahul Mhaskar, et al.
Pageof 17